IMMUNOVEDA

Serial Number 98022884
Registration 7420173
700

Registration Progress

Application Filed
Jun 1, 2023
Under Examination
Approved for Publication
Apr 2, 2024
Published for Opposition
Apr 2, 2024
Registered
Jun 18, 2024

Trademark Image

IMMUNOVEDA

Basic Information

Serial Number
98022884
Registration Number
7420173
Filing Date
June 1, 2023
Registration Date
June 18, 2024
Published for Opposition
April 2, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 18, 2024
Registration
Registered
Classes
042

Rights Holder

Genesis Drug, Discovery & Development, LLC

16
Address
Law Department
2439 Kuser Road
Hamilton, NJ 08690

Ownership History

Genesis Drug, Discovery & Development, LLC

Original Applicant
16
Hamilton, NJ

Genesis Drug, Discovery & Development, LLC

Owner at Publication
16
Hamilton, NJ

Genesis Drug, Discovery & Development, LLC

Original Registrant
16
Hamilton, NJ

Legal Representation

Attorney
Christina E. Brule

USPTO Deadlines

Next Deadline
1636 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240618)
Due Date
June 18, 2030
Grace Period Ends
December 18, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

13 events
Date Code Type Description Documents
Jun 18, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 18, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 2, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 2, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 13, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 23, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 23, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 15, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Sep 15, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 15, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 15, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 5, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 5, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Providing laboratory research services in the field of gene expression, namely, cancer biology
First Use Anywhere: 20201100
First Use in Commerce: 20201100

Classification

International Classes
042